Please login to the form below

Not currently logged in

Fred Powell joins Celator as chief financial officer

Joins oncology specialist from OraPharma

Fred Powell, Celator Celator has hired Fred Powell as chief financial officer.

He joins from OraPharma, and will be responsible for the oncology specialist's accounting, corporate finance, financial planning, investor relations and administration functions.

"Fred brings a tremendous skill set and experience base to a company at our stage, with a 20-year track record in the biopharmaceutical industry that includes private and public financings, mergers and acquisitions, and domestic and global operations,” said Scott Jackson, CEO of Celator Pharmaceuticals.

“He will make an immediate and substantive contribution to our success."

During his time at OraPharma, Powell helped the company through several transitions, helping to establish it as a stand-alone business after its sale by Johnson & Johnson in late 2010, and then supporting its acquisition by Valeant Pharmaceuticals in June, 2012.

Prior to joining OraPharma, he was the chief financial officer of BMP Sunstone Corporation, a US specialty pharmaceutical, overseeing its eventual sale to Sanofi.

Powell also held senior finance and administration positions at Eximias Pharmaceutical Corporation, Innaphase Corporation, and ERT (formerly EResearch Technology).

20th December 2012

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company

Our higher purpose is to deliver better communication to increase and speed up the ability of patients to access better...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...